Soft Tissue Injury

Also known as: Soft Tissue Injuries / Soft tissue injury NOS / Soft tissue injury (disorder)

Drug	Drug Name	Drug Description
DB06774	Capsaicin	A topical analgesic agent used for the symptomatic relief of neuropathic pain associated with post-herpetic neuralgia, as well as other muscle and joint pain.
DB09214	Dexketoprofen	An NSAID that is the R(-)-enantiomer of racemic ketoprofen with analgesic and anti-inflammatory properties used for the treatment of mild to moderate pain.
DB00281	Lidocaine	A local anesthetic used in a wide variety of superficial and invasive procedures.
DB09212	Loxoprofen	An NSAID used to treat pain and inflammation in musculoskeletal conditions.
DB11582	Thiocolchicoside	A semi-synthetic colchicine derivative used as an analgesic and anti-inflammatory.

Drug	Drug Name	Target	Type
DB06774	Capsaicin	Cytochrome P450 3A4	enzyme
DB06774	Capsaicin	Prostaglandin G/H synthase 2	enzyme
DB06774	Capsaicin	Myeloperoxidase	enzyme
DB06774	Capsaicin	Cytochrome P450 1A2	enzyme
DB06774	Capsaicin	Cytochrome P450 2E1	enzyme
DB06774	Capsaicin	Amine oxidase [flavin-containing] A	enzyme
DB06774	Capsaicin	Dopamine beta-hydroxylase	enzyme
DB06774	Capsaicin	Glutamine synthetase	enzyme
DB06774	Capsaicin	Cholinesterase	enzyme
DB06774	Capsaicin	Transient receptor potential cation channel subfamily V member 1	target
DB06774	Capsaicin	Prohibitin-2	target
DB09214	Dexketoprofen	Prostaglandin G/H synthase 1	target
DB09214	Dexketoprofen	Prostaglandin G/H synthase 2	target
DB09214	Dexketoprofen	Prostaglandin G/H synthase 1	enzyme
DB09214	Dexketoprofen	Prostaglandin G/H synthase 2	enzyme
DB00281	Lidocaine	Sodium channel protein type 5 subunit alpha	target
DB00281	Lidocaine	Sodium channel protein type 10 subunit alpha	target
DB00281	Lidocaine	Epidermal growth factor receptor	target
DB00281	Lidocaine	Sodium channel protein type 9 subunit alpha	target
DB00281	Lidocaine	Cytochrome P450 1A2	enzyme
DB00281	Lidocaine	Cytochrome P450 2D6	enzyme
DB00281	Lidocaine	Cytochrome P450 3A4	enzyme
DB00281	Lidocaine	Cytochrome P450 3A5	enzyme
DB00281	Lidocaine	Cytochrome P450 3A7	enzyme
DB00281	Lidocaine	Solute carrier family 22 member 5	transporter
DB00281	Lidocaine	P-glycoprotein 1	transporter
DB00281	Lidocaine	Cytochrome P450 2A6	enzyme
DB00281	Lidocaine	Cytochrome P450 2B6	enzyme
DB00281	Lidocaine	Cytochrome P450 2C8	enzyme
DB00281	Lidocaine	Cytochrome P450 2C9	enzyme
DB00281	Lidocaine	Sodium channel protein type 4 subunit alpha	target
DB00281	Lidocaine	Alpha-1-acid glycoprotein 1	target
DB00281	Lidocaine	Alpha-1-acid glycoprotein 2	target
DB09212	Loxoprofen	Prostaglandin G/H synthase 2	target
DB09212	Loxoprofen	Prostaglandin G/H synthase 1	target
DB09212	Loxoprofen	Carbonyl reductase [NADPH] 1	enzyme
DB09212	Loxoprofen	Cytochrome P450 3A Subfamily	enzyme
DB09212	Loxoprofen	UDP-glucuronosyltransferase 2B7	enzyme
DB11582	Thiocolchicoside	GABA(A) Receptor	target
DB11582	Thiocolchicoside	Glycine receptor subunit alpha-1	target
DB11582	Thiocolchicoside	Tumor necrosis factor ligand superfamily member 11	target

Drug	Drug Name	Phase	Status	Count
DB00316	Acetaminophen	2	Completed	1
DB00586	Diclofenac	2	Completed	1
DB16159	Esflurbiprofen	2	Completed	1
DB01050	Ibuprofen	2	Completed	1
DB00788	Naproxen	2	Completed	1
DB00586	Diclofenac	3	Completed	1
DB00586	Diclofenac	3	Recruiting	1
DB00692	Phentolamine	3	Not Yet Recruiting	1
DB00586	Diclofenac	Not Available	Completed	1
DB01050	Ibuprofen	Not Available	Terminated	1
DB09543	Methyl salicylate	Not Available	Completed	1